Navigation Links
Elsevier journal Translational Proteomics endorsed by the Human Proteome Organization
Date:5/5/2014

Cambridge, MA, May 5, 2014 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the Human Proteome Organization (HUPO) are delighted to announce HUPO's affiliation with Elsevier's new, open access journal, Translational Proteomics.

HUPO is an international scientific organization that represents and promotes proteomics through worldwide cooperation and collaborations. HUPO plays an essential role in the development and implementation of standards and policies in proteomics research as well as determining how proteins play a role in human health and disease.

As such, Elsevier is delighted that its open access journal Translational Proteomics can fill an important need for the organization helping them with the dissemination of translational discoveries.

Translational Proteomics covers all areas of human proteomics using multi-disciplinary approaches to untangle complex disease processes. The journal emphasizes linking basic proteomic sciences to clinical research, from patient to bench to bedside, an important component of proteomics research that the HUPO embraces.

"HUPO is very pleased to provide its membership with significant benefits from this new collaboration with Translational Proteomics and Elsevier and we look forward to a long and fruitful relationship," explains Maxey C.M. Chung, HUPO Secretary General.

"We are really excited about this new collaboration with HUPO", says Jean-Charles Sanchez, Editor-in-Chief of Translational Proteomics. "Both HUPO and Translational Proteomics aim to cover and disseminate knowledge across all areas of human proteomics using multi-disciplinary approaches to untangle complex disease processes. The journal provides space for publications of the Biology/Disease Human Proteome Project (HPP) initiatives."

Elsevier will also annually sponsor the 'HUPO Translational Proteomics Award'. The award is in recognition of a scientist for distinguished scientific achievements in the field of Translational Proteomics and will be awarded at the annual HUPO meeting.

HUPO members will receive 25% discount on the open access author fees when their articles are published in Translational Proteomics.


'/>"/>

Contact: Paige Shaklee
P.Shaklee@elsevier.com
617-397-2882
Elsevier
Source:Eurekalert

Related biology news :

1. Elsevier announces the launch of a new journal: Geoderma Regional
2. Elsevier announces the launch of OA journal: Colloid and Interface Science Communications
3. Elsevier and Energy Institute work together to publish Journal of the Energy Institute
4. Elsevier announces the launch of open access journal: Pathogenesis
5. Elsevier announces the launch of open access journal: Current Plant Biology
6. Elseviers Biochimica et Biophysica Acta (BBA) journal series adds open access journal: BBA Clinical
7. Elsevier launches new open access journal: Photoacoustics
8. Elseviers Maturitas publishes position statement on fertility preservation
9. Elsevier launches new open access journal in biomedicine
10. Elsevier announces the launch of a new open access journal: Water Resources and Industry
11. Elsevier launches first video journal in gastrointestinal endoscopy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
Breaking Biology Technology: